131 related articles for article (PubMed ID: 37414253)
21. Local control and toxicity outcomes of stereotactic radiosurgery for spinal metastases of gastrointestinal origin.
Sandhu N; Benson KRK; Kumar KA; Eyben RV; Chang DT; Gibbs IC; Hancock SL; Meola A; Chang SD; Li G; Hayden-Gephart M; Soltys SG; Pollom EL
J Neurosurg Spine; 2020 Mar; 33(1):87-94. PubMed ID: 32114530
[TBL] [Abstract][Full Text] [Related]
22. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.
Thibault I; Al-Omair A; Masucci GL; Masson-Côté L; Lochray F; Korol R; Cheng L; Xu W; Yee A; Fehlings MG; Bjarnason GA; Sahgal A
J Neurosurg Spine; 2014 Nov; 21(5):711-8. PubMed ID: 25170656
[TBL] [Abstract][Full Text] [Related]
23. Mature Local Control and Reirradiation Rates Comparing Spine Stereotactic Body Radiation Therapy With Conventional Palliative External Beam Radiation Therapy.
Zeng KL; Myrehaug S; Soliman H; Husain ZA; Tseng CL; Detsky J; Ruschin M; Atenafu EG; Witiw CD; Larouche J; da Costa L; Maralani PJ; Parulekar WR; Sahgal A
Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):293-300. PubMed ID: 35675854
[TBL] [Abstract][Full Text] [Related]
24. Toxicity and Efficacy of Multitarget Thoracic Stereotactic Body Radiation Therapy.
Nguyen EK; Poon I; Ung YC; Tsao M; Korol R; Elzibak AH; Erler D; Zhang L; Louie AV; Cheung P
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(4):897-905. PubMed ID: 36368432
[TBL] [Abstract][Full Text] [Related]
25. Local control and patterns of failure for "Radioresistant" spinal metastases following stereotactic body radiotherapy compared to a "Radiosensitive" reference.
Zeng KL; Sahgal A; Husain ZA; Myrehaug S; Tseng CL; Detsky J; Sarfehnia A; Ruschin M; Campbell M; Foster M; Das S; Lipsman N; Bjarnason GA; Atenafu EG; Maralani PJ; Soliman H
J Neurooncol; 2021 Mar; 152(1):173-182. PubMed ID: 33453002
[TBL] [Abstract][Full Text] [Related]
26. Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC).
von Reibnitz D; Shaikh F; Wu AJ; Treharne GC; Dick-Godfrey R; Foster A; Woo KM; Shi W; Zhang Z; Din SU; Gelblum DY; Yorke ED; Rosenzweig KE; Rimner A
Acta Oncol; 2018 Nov; 57(11):1567-1573. PubMed ID: 29873277
[TBL] [Abstract][Full Text] [Related]
27. SEOR SBRT-SG stereotactic body radiation therapy consensus guidelines for non-spine bone metastasis.
Lopez-Campos F; Cacicedo J; Couñago F; García R; Leaman-Alcibar O; Navarro-Martin A; Pérez-Montero H; Conde-Moreno A
Clin Transl Oncol; 2022 Feb; 24(2):215-226. PubMed ID: 34633602
[TBL] [Abstract][Full Text] [Related]
28. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
Voglhuber T; Kessel KA; Oechsner M; Vogel MME; Gschwend JE; Combs SE
BMC Cancer; 2020 Jun; 20(1):536. PubMed ID: 32513136
[TBL] [Abstract][Full Text] [Related]
29. Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases.
Andratschke N; Parys A; Stadtfeld S; Wurster S; Huttenlocher S; Imhoff D; Yildirim M; Rades D; Rödel CM; Dunst J; Hildebrandt G; Blanck O
Radiat Oncol; 2016 May; 11():74. PubMed ID: 27236333
[TBL] [Abstract][Full Text] [Related]
30. Stereotactic body radiotherapy for bone metastases in patients with colorectal cancer.
Ito K; Yamaguchi T; Ogawa H; Nakajima Y; Karasawa K
Jpn J Clin Oncol; 2020 Dec; 50(12):1442-1446. PubMed ID: 32719860
[TBL] [Abstract][Full Text] [Related]
31. Stereotactic body radiation therapy for medically inoperable early-stage lung cancer: Tata Memorial Hospital perspective and practice recommendations.
Agarwal JP; Pilar A; Mummudi N; Gupta M; Laskar SG; Pathak RS; Tibdewal AR; Kinhikar R; Ghadi Y; Tandon S; Purandare N; Prabhash K; Patil V
Indian J Cancer; 2020; 57(1):18-24. PubMed ID: 31929233
[TBL] [Abstract][Full Text] [Related]
32. Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial.
Sprave T; Verma V; Förster R; Schlampp I; Hees K; Bruckner T; Bostel T; El Shafie RA; Welzel T; Nicolay NH; Debus J; Rief H
BMC Cancer; 2018 Aug; 18(1):859. PubMed ID: 30170568
[TBL] [Abstract][Full Text] [Related]
33. Association of tumor genomic factors and efficacy for metastasis-directed stereotactic body radiotherapy for oligometastatic colorectal cancer.
Jethwa KR; Jang S; Mullikin TC; Harmsen WS; Petersen MM; Olivier KR; Park SS; Neben-Wittich MA; Hubbard JM; Sandhyavenu H; Whitaker TJ; Waltman LA; Kipp BR; Merrell KW; Haddock MG; Hallemeier CL
Radiother Oncol; 2020 May; 146():29-36. PubMed ID: 32114263
[TBL] [Abstract][Full Text] [Related]
34. Radiological changes on CT after stereotactic body radiation therapy to non-spine bone metastases: a descriptive series.
Chiu N; Probyn L; Raman S; McDonald R; Poon I; Erler D; Brotherston D; Soliman H; Cheung P; Chung H; Chu W; Loblaw A; Thavarajah N; Lang C; Chin L; Chow E; Sahgal A
Ann Palliat Med; 2016 Apr; 5(2):116-24. PubMed ID: 27121739
[TBL] [Abstract][Full Text] [Related]
35. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
[TBL] [Abstract][Full Text] [Related]
36. PSMA-PET/CT-Based Stereotactic Body Radiotherapy (SBRT) in the Treatment of Uncomplicated Non-Spinal Bone Oligometastases from Prostate Cancer.
Pastorello E; Nicosia L; Cuccia F; Olivari L; Fiorini M; Giaj Levra N; Mazzola R; Ricchetti F; Rigo M; Ravelli P; D'Alessandro S; Salgarello M; Ruggieri R; Alongi F
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345138
[TBL] [Abstract][Full Text] [Related]
37. Significance of liver metastasis volume in breast cancer patients treated with stereotactic body radiotherapy.
Oymak E; Guler OC; Onal C
Strahlenther Onkol; 2022 Mar; 198(3):247-253. PubMed ID: 34477885
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic body radiotherapy as a primary treatment for spinal metastasis: a single institution experience.
Yeung WME
Ann Palliat Med; 2020 Nov; 9(6):4467-4477. PubMed ID: 33302690
[TBL] [Abstract][Full Text] [Related]
39. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
Aoki M; Sato M; Hirose K; Akimoto H; Kawaguchi H; Hatayama Y; Ono S; Takai Y
Radiat Oncol; 2015 Apr; 10():99. PubMed ID: 25897487
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy.
Gutkin PM; Gore E; Charlson J; Neilson JC; Johnstone C; King DM; Hackbarth DA; Wooldridge A; Mannem R; Bedi M
Radiat Oncol; 2023 Mar; 18(1):42. PubMed ID: 36859309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
